Researchers analyzed GPT-4’s performance in four clinical decision support scenarios generating clinical vignettes, diagnostic reasoning, clinical plan generation and subjective patient assessments
Adding an FDA-Approved Version of the Common Dietary Supplement Glutamine to Standard Therapy Improved Outcomes in Patients With Advanced Disease, Prompting Further Clinical Trials